Desempeño analítico - MENSUAL

Desempeño analítico - MENSUAL Sep-11 165 Lab (Mód) Analizador Control Lote Analito Unid Activo ETa Laboratorio Criterio Valor Grupo PAR (Acum) 2 Axsym BIORAD 40240 AFP 1 Variabilidad biológica 22.0% 2 19.10 6.30% 27 19.26 5.72% 12 40240 Abbott ARCHITECT i4000 0.8% 12.3% 3.70 2 Axsym BIORAD 40240 AFP ng/ml 1 Variabilidad biológica 22.0% 2 98.7 6.80% 23 99.9 4.33% 13 40240 Abbott ARCHITECT i4000 1.2% 9.9% 4.80 2 Axsym BIORAD 40240 AFP ng/ml Variabilidad biológica 22.0% 2 212 9.90% 15 40240 Abbott ARCHITECT i4000 1 Architect BIORAD 40240 CEA ng/ml 1 Variabilidad biológica 25.0% 1 2.97 8.50% 32 3.17 3.80% 35 40240 Abbott ARCHITECT i4000 6.7% 14.3% 4.81 1 Architect BIORAD 40240 CEA ng/ml 1 Variabilidad biológica 25.0% 1 21.3 4.60% 26 21.2 3.20% 36 40240 Abbott ARCHITECT i4000-0.4% 6.8% 7.70 1 Architect BIORAD 40240 CEA ng/ml 1 Variabilidad biológica 25.0% 1 48.9 4.70% 27 48.2 2.20% 35 40240 Abbott ARCHITECT i4000-1.4% 5.8% 10.72 1 Architect BIORAD 40240 INS 1 NYS 25.0% 1 13.02 4.30% 29 12.54 3.80% 44 40240 Abbott ARCHITECT i4000-3.7% 11.3% 5.61 1 Architect BIORAD 40240 INS uui/ml 1 NYS 25.0% 1 41.7 4.00% 22 40.6 2.10% 43 40240 Abbott ARCHITECT i4000-2.5% 6.7% 10.69 1 Architect BIORAD 40240 INS uui/ml 1 NYS 25.0% 1 125.6 3.50% 25 123.3 2.10% 44 40240 Abbott ARCHITECT i4000-1.8% 6.0% 11.03 1 Architect BIORAD 40240 PSA ng/ml 1 Variabilidad biológica 34.0% 1 0.655 5.90% 66 0.622 5.20% 38 40240 Abbott ARCHITECT i4000-5.0% 15.4% 5.57 1 Architect BIORAD 40240 PSA ng/ml 1 Variabilidad biológica 34.0% 1 2.51 6.20% 58 2.36 5.50% 37 40240 Abbott ARCHITECT i4000-6.0% 17.0% 5.10 1 Architect BIORAD 40240 PSA ng/ml 1 Variabilidad biológica 34.0% 1 15.47 6.80% 60 15.11 5.20% 37 40240 Abbott ARCHITECT i4000-2.3% 12.7% 6.09 1 Architect BIORAD 40240 PSAL 1 3SD GP 20.0% 1 0.425 5.70% 46 0.419 2.90% 26 40240 Abbott ARCHITECT i4000-1.4% 7.2% 6.41 1 Architect BIORAD 40240 PSAL ng/ml 1 3SD GP 20.0% 1 1.600 5.70% 42 1.570 2.60% 25 40240 Abbott ARCHITECT i4000-1.9% 7.1% 6.97 1 Architect BIORAD 40240 PSAL ng/ml 3SD GP 20.0% 1 11.19 7.30% 44 11.19 5.80% 11 40240 Abbott ARCHITECT i4000 0.0% 11.6% 3.45 1 Architect BIORAD 40240 T3 ng/dl 1 RCPA 28.2% 1 69.2 10.90% 37 68.4 5.60% 34 40240 Abbott ARCHITECT i4000-1.2% 12.4% 4.82 1 Architect BIORAD 40240 T3 ng/dl 1 RCPA 20.0% 1 195.3 6.00% 38 195.8 2.40% 35 40240 Abbott ARCHITECT i4000 0.3% 5.1% 8.23 1 Architect BIORAD 40240 T3 ng/dl 1 RCPA 20.0% 1 278 7.00% 34 280 2.20% 35 40240 Abbott ARCHITECT i4000 0.6% 5.0% 8.80 1 Architect BIORAD 40240 T3L 1 AAB 30.0% 1 2.06 11.50% 50 1.940 4.60% 14 40240 Abbott ARCHITECT i4000-5.8% 15.0% 5.26 1 Architect BIORAD 40240 T3L pg/ml 1 AAB 30.0% 1 6.17 7.80% 45 6.03 3.30% 13 40240 Abbott ARCHITECT i4000-2.3% 8.9% 8.40 1 Architect BIORAD 40240 T3L pg/ml 1 AAB 30.0% 1 11.15 7.80% 43 11.00 4.40% 13 40240 Abbott ARCHITECT i4000-1.3% 10.1% 6.51 1 Architect BIORAD 40240 T4L ng/dl 1 RCPA 15.0% 1 0.899 5.90% 81 0.880 2.80% 43 40240 Abbott ARCHITECT i4000-2.1% 7.7% 4.60 1 Architect BIORAD 40240 T4L ng/dl 1 RCPA 15.0% 1 2.29 6.20% 75 2.29 3.40% 40 40240 Abbott ARCHITECT i4000 0.0% 6.8% 4.41 1 Architect BIORAD 40240 TSH 1 Variabilidad biológica 24.0% 1 0.410 6.10% 84 0.389 5.00% 40 40240 Abbott ARCHITECT i4000-5.1% 15.1% 3.78 1 Architect BIORAD 40240 TSH uui/ml 1 Variabilidad biológica 24.0% 1 4.45 6.00% 79 4.28 2.70% 39 40240 Abbott ARCHITECT i4000-3.8% 9.2% 7.47 1 Architect BIORAD 40240 TSH uui/ml 1 Variabilidad biológica 24.0% 1 27.3 8.30% 78 27.6 2.40% 39 40240 Abbott ARCHITECT i4000 1.2% 6.0% 9.48 2 Immulite BIORAD 40240 BHCG 1 CFX 32.0% 2 5.71 15.20% 33 5.01 8.10% 26 40240 Siemens IMMULITE 2000-12.3% 28.5% 2.44 2 Immulite BIORAD 40240 BHCG mui/ml 1 CFX 32.0% 2 30.1 11.30% 33 26.9 7.10% 26 40240 Siemens IMMULITE 2000-10.7% 24.9% 2.99 2 Immulite BIORAD 40240 BHCG mui/ml 1 CFX 32.0% 2 262 7.70% 33 255 5.30% 26 40240 Siemens IMMULITE 2000-2.8% 13.4% 5.51 2 Architect BIORAD 40240 CORT 1 Variabilidad biológica 30.0% 2 2.59 10.40% 33 2.71 5.80% 25 40240 Abbott ARCHITECT i4000 4.6% 16.2% 4.37 2 Architect BIORAD 40240 CORT ug/dl 1 Variabilidad biológica 30.0% 2 15.40 6.40% 30 15.30 4.30% 28 40240 Abbott ARCHITECT i4000-0.6% 9.2% 6.83 2 Architect BIORAD 40240 CORT ug/dl 1 Variabilidad biológica 30.0% 2 25.9 6.40% 28 25.5 3.80% 27 40240 Abbott ARCHITECT i4000-1.8% 9.4% 7.43 2 Immulite BIORAD 40240 D4 1 Variabilidad biológica 46.0% 2 1.220 15.70% 15 1.180 9.20% 13 40240 Siemens IMMULITE 2000-3.3% 21.7% 4.64 2 Immulite BIORAD 40240 D4 ng/ml 1 Variabilidad biológica 46.0% 2 5.51 11.30% 15 5.27 7.30% 14 40240 Siemens IMMULITE 2000-4.4% 19.0% 5.70 2 Immulite BIORAD 40240 D4 ng/ml Variabilidad biológica 46.0% 2 14.52 15.60% 4 40240 Siemens IMMULITE 2000 Media Nº Labs CV Media CV Lote Analizador NºRes Sesgo (CCI) Laboratorio ET Sigma Fecha de impresión: 08/11/2011 Página 1/4

Desempeño analítico - MENSUAL Sep-11 165 Lab (Mód) Analizador Control Lote Analito Unid Activo ETa Laboratorio Criterio Valor Grupo PAR (Acum) Media Nº Labs CV Media CV Lote Analizador NºRes Sesgo (CCI) Laboratorio 2 Immulite BIORAD 40240 DFH 1 CLIA 25.0% 2 6.59 9.30% 9 6.49 7.00% 12 40240 Siemens IMMULITE 2000-1.5% 15.5% 3.35 ET Sigma 2 Immulite BIORAD 40240 DFH ug/ml CLIA 25.0% 2 13.59 7.70% 8 40240 Siemens IMMULITE 2000 2 Immulite BIORAD 40240 DFH ug/ml 1 CLIA 25.0% 2 23.1 7.60% 7 23.3 5.40% 13 40240 Siemens IMMULITE 2000 0.8% 11.6% 4.48 1 Architect BIORAD 40240 DHEAS 1 3DS CCI 30.0% 1 78.2 5.40% 20 76.3 4.00% 33 40240 Abbott ARCHITECT i4000-2.4% 10.4% 6.90 1 Architect BIORAD 40240 DHEAS ug/dl 1 3DS CCI 30.0% 1 160.4 4.40% 17 159.7 3.50% 31 40240 Abbott ARCHITECT i4000-0.4% 7.4% 8.45 1 Architect BIORAD 40240 DHEAS ug/dl 1 3DS CCI 30.0% 1 656 4.70% 18 665 3.50% 31 40240 Abbott ARCHITECT i4000 1.4% 8.4% 8.18 2 Architect BIORAD 40240 E2 1 RCPA 46.4% 2 64.6 9.50% 56 61.9 12.30% 42 40240 Abbott ARCHITECT i4000-4.2% 28.8% 3.43 2 Architect BIORAD 40240 E2 pg/ml 1 RCPA 25.0% 2 185.4 4.40% 50 178.6 2.70% 45 40240 Abbott ARCHITECT i4000-3.7% 9.1% 7.90 2 Architect BIORAD 40240 E2 pg/ml 1 RCPA 25.0% 2 296 3.60% 55 287 2.40% 44 40240 Abbott ARCHITECT i4000-2.9% 7.7% 9.19 2 Immulite BIORAD 40240 FENO 1 CLIA 20.0% 2 8.51 5.20% 2 8.43 4.70% 21 40240 Abbott ARCHITECT c8000-0.9% 10.3% 4.06 2 Immulite BIORAD 40240 FENO ug/ml CLIA 20.0% 2 40240 Abbott ARCHITECT c8000 2 Immulite BIORAD 40240 FENO ug/ml 1 CLIA 20.0% 2 50.4 3.80% 1 51.4 4.90% 19 40240 Abbott ARCHITECT c8000 1.9% 11.7% 3.70 2 Architect BIORAD 40240 FER 1 Variabilidad biológica 25.0% 2 66.5 5.50% 49 69.3 3.67% 19 40240 Abbott ARCHITECT i4000 4.2% 11.6% 5.66 2 Architect BIORAD 40240 FER ng/ml 1 Variabilidad biológica 25.0% 2 152.2 10.30% 35 167.7 4.85% 23 40240 Abbott ARCHITECT i4000 10.2% 19.9% 3.05 2 Architect BIORAD 40240 FER ng/ml 1 Variabilidad biológica 25.0% 2 383 9.40% 40 401 5.41% 30 40240 Abbott ARCHITECT i4000 4.6% 15.4% 3.77 2 Immulite BIORAD 40240 FOL 1 AAB 33.5% 2 2.69 10.80% 17 2.84 5.60% 13 40240 Siemens IMMULITE 2000 5.6% 16.8% 4.98 2 Immulite BIORAD 40240 FOL ng/ml AAB 30.0% 2 6.76 9.60% 16 40240 Siemens IMMULITE 2000 2 Immulite BIORAD 40240 FOL ng/ml 1 AAB 30.0% 2 12.40 9.30% 15 12.84 7.40% 11 40240 Siemens IMMULITE 2000 3.5% 18.3% 3.57 2 Architect BIORAD 40240 FSH 1 Variabilidad biológica 19.0% 2 8.01 7.20% 52 7.58 3.80% 43 40240 Abbott ARCHITECT i4000-5.4% 13.0% 3.59 2 Architect BIORAD 40240 FSH mui/ml 1 Variabilidad biológica 19.0% 2 22.3 5.60% 45 21.2 2.20% 41 40240 Abbott ARCHITECT i4000-5.2% 9.6% 6.30 2 Architect BIORAD 40240 FSH mui/ml 1 Variabilidad biológica 19.0% 2 37.4 6.00% 49 35.8 2.20% 41 40240 Abbott ARCHITECT i4000-4.2% 8.6% 6.73 2 Immulite BIORAD 40240 IGE 1 AAB 30.0% 2 181.6 10.30% 31 176.8 5.91% 33 40240 Siemens IMMULITE 2000-2.6% 14.5% 4.63 2 Immulite BIORAD 40240 IGE UI/mL 1 AAB 30.0% 2 92.0 9.10% 25 92.2 5.50% 33 40240 Siemens IMMULITE 2000 0.2% 11.2% 5.42 2 Immulite BIORAD 40240 IGE UI/mL AAB 30.0% 2 112.2 9.30% 26 40240 Siemens IMMULITE 2000 2 Architect BIORAD 40240 LH 1 Variabilidad biológica 20.0% 2 1.450 9.30% 52 1.450 3.40% 40 40240 Abbott ARCHITECT i4000 0.0% 6.8% 5.88 2 Architect BIORAD 40240 LH mui/ml 1 Variabilidad biológica 20.0% 2 16.66 6.40% 45 16.35 3.30% 39 40240 Abbott ARCHITECT i4000-1.9% 8.5% 5.50 2 Architect BIORAD 40240 LH mui/ml 1 Variabilidad biológica 20.0% 2 49.8 7.10% 48 49.0 2.40% 39 40240 Abbott ARCHITECT i4000-1.7% 6.5% 7.61 2 Architect BIORAD 40240 PG 1 AAB 42.9% 2 0.653 10.10% 48 0.588 8.80% 33 40240 Abbott ARCHITECT i4000-10.0% 27.6% 3.74 2 Architect BIORAD 40240 PG ng/ml 1 AAB 30.0% 2 7.59 6.90% 42 7.34 3.70% 31 40240 Abbott ARCHITECT i4000-3.3% 10.7% 7.22 2 Architect BIORAD 40240 PG ng/ml 1 AAB 30.0% 2 28.2 9.80% 45 27.2 5.50% 31 40240 Abbott ARCHITECT i4000-3.4% 14.4% 4.83 2 Immulite BIORAD 40240 PPC 1 Variabilidad biológica 31.2% 2 0.970 7.00% 13 1.000 1.90% 9 40240 Siemens IMMULITE 2000 3.1% 6.9% 14.79 2 Immulite BIORAD 40240 PPC ng/ml 1 Variabilidad biológica 31.2% 2 4.56 5.80% 14 4.57 3.50% 9 40240 Siemens IMMULITE 2000 0.2% 7.2% 8.85 2 Immulite BIORAD 40240 PPC ng/ml Variabilidad biológica 31.2% 2 6.76 5.80% 10 40240 Siemens IMMULITE 2000 2 Architect BIORAD 40240 PRL 1 Variabilidad biológica 21.0% 2 6.86 5.90% 47 6.98 3.60% 33 40240 Abbott ARCHITECT i4000 1.7% 8.9% 5.35 2 Architect BIORAD 40240 PRL ng/ml 1 Variabilidad biológica 21.0% 2 22.3 6.30% 42 22.4 3.10% 34 40240 Abbott ARCHITECT i4000 0.6% 6.8% 6.59 2 Architect BIORAD 40240 PRL ng/ml 1 Variabilidad biológica 21.0% 2 49.2 7.90% 44 49.7 3.90% 32 40240 Abbott ARCHITECT i4000 1.0% 8.8% 5.13 2 Architect BIORAD 40240 PTH 1 Variabilidad biológica 30.0% 2 22.4 21.30% 8 22.8 7.70% 37 40240 Abbott ARCHITECT i4000 1.6% 17.0% 3.69 2 Architect BIORAD 40240 PTH pg/ml 1 Variabilidad biológica 30.0% 2 110.1 31.20% 8 107.0 6.70% 33 40240 Abbott ARCHITECT i4000-2.8% 16.2% 4.06 2 Architect BIORAD 40240 PTH pg/ml 1 Variabilidad biológica 30.0% 2 389 33.80% 8 375 6.80% 34 40240 Abbott ARCHITECT i4000-3.5% 17.1% 3.89 Fecha de impresión: 08/11/2011 Página 2/4

Desempeño analítico - MENSUAL Sep-11 165 Lab (Mód) Analizador Control Lote Analito Unid Activo ETa Laboratorio Criterio Valor Grupo PAR (Acum) Media Nº Labs CV Media CV Lote Analizador NºRes Sesgo (CCI) Laboratorio 2 Architect BIORAD 40240 T4 1 AAB 20.0% 2 5.01 8.30% 44 5.12 4.00% 24 40240 Abbott ARCHITECT i4000 2.2% 10.2% 4.45 2 Architect BIORAD 40240 T4 ug/dl 1 AAB 20.0% 2 11.43 6.20% 42 10.72 6.80% 26 40240 Abbott ARCHITECT i4000-6.2% 19.8% 2.03 2 Architect BIORAD 40240 T4 ug/dl 1 AAB 20.0% 2 18.29 6.70% 38 17.53 7.30% 23 40240 Abbott ARCHITECT i4000-4.2% 18.8% 2.17 ET Sigma 2 Architect BIORAD 40240 T4L 1 2 1 5.90% 81 40240 Abbott ARCHITECT i4000 2 Architect BIORAD 40240 T4L 1 2 2.29 6.20% 75 40240 Abbott ARCHITECT i4000 2 Architect BIORAD 40240 T4L 2 4.57 8.40% 56 40240 Abbott ARCHITECT i4000 2 Architect BIORAD 40240 TO 1 AAB 30.0% 2 1.440 8.00% 25 1.380 5.90% 31 40240 Abbott ARCHITECT i4000-4.2% 16.0% 4.38 2 Architect BIORAD 40240 TO ng/ml 1 AAB 30.0% 2 5.33 6.10% 23 5.78 1.30% 29 40240 Abbott ARCHITECT i4000 8.4% 11.0% 16.58 2 Architect BIORAD 40240 TO ng/ml 1 AAB 30.0% 2 9.54 5.40% 25 10.19 2.90% 34 40240 Abbott ARCHITECT i4000 6.8% 12.6% 8.00 2 Architect BIORAD 40240 TSH 1 Variabilidad biológica 24.0% 2 0 6.10% 84 0 2.40% 47 40240 Abbott ARCHITECT i4000-2.7% 7.5% 8.88 2 Architect BIORAD 40240 TSH uui/ml 1 Variabilidad biológica 24.0% 2 4.45 6.00% 79 4.33 2.80% 46 40240 Abbott ARCHITECT i4000-2.7% 8.3% 7.61 2 Architect BIORAD 40240 TSH uui/ml 1 Variabilidad biológica 24.0% 2 27.3 8.30% 78 27.7 3.20% 44 40240 Abbott ARCHITECT i4000 1.5% 7.9% 7.03 2 Immulite BIORAD 40240 VALP 1 CLIA 25.0% 2 32.5 5.20% 11 31.8 3.50% 26 40240 Siemens IMMULITE 2000-2.1% 9.1% 6.54 2 Immulite BIORAD 40240 VALP ug/ml CLIA 25.0% 2 77.7 5.20% 10 40240 Siemens IMMULITE 2000 2 Immulite BIORAD 40240 VALP ug/ml 1 CLIA 25.0% 2 126.6 4.50% 10 124.8 3.20% 26 40240 Siemens IMMULITE 2000-1.4% 7.8% 7.37 2 Architect BIORAD 40240 VB12 1 AAB 30.0% 2 434 10.30% 30 426 6.40% 16 40240 Abbott ARCHITECT i4000-1.9% 14.7% 4.40 2 Architect BIORAD 40240 VB12 pg/ml 1 AAB 30.0% 2 592 7.80% 26 588 4.80% 18 40240 Abbott ARCHITECT i4000-0.7% 10.3% 6.11 2 Architect BIORAD 40240 VB12 pg/ml 1 AAB 30.0% 2 1286 9.50% 21 1307 5.50% 16 40240 Abbott ARCHITECT i4000 1.6% 12.6% 5.16 2 Architect # REF! 19860 B2MG # REF! 1 AAB 30.0% 2 1501 8.20% 11 1621 2.10% 2 19860 Siemens IMMULITE 2000 8.0% 12.2% 10.48 2 Architect BioTum 19860 B2MG ng/ml 1 AAB 30.0% 2 3081 7.90% 9 3156 2.30% 12 19860 Siemens IMMULITE 2000 2.4% 7.0% 11.99 2 Architect # REF! 19860 B2MG # REF! 1 AAB 30.0% 2 5769 8.20% 10 5892 4.20% 13 19860 Siemens IMMULITE 2000 2.1% 10.5% 6.64 2 Architect 19860 Ca 19-9 1 Variabilidad biológica 39.0% 2 14.31 10.50% 6 13.98 3.50% 5 19860 Abbott AxSYM -2.3% 9.3% 10.48 2 Architect BioTum 19860 Ca 19-9 U/mL 1 Variabilidad biológica 39.0% 2 88.2 8.40% 6 87.5 7.90% 29 19860 Abbott AxSYM -0.7% 16.5% 4.84 2 Architect 19860 Ca 19-9 U/mL 1 Variabilidad biológica 39.0% 2 284 7.60% 5 301 5.60% 28 19860 Abbott AxSYM 5.8% 17.0% 5.92 1 Architect 19860 Ca 125 1 Variabilidad biológica 18.0% 1 53.4 5.90% 31 52.1 1.60% 5 19860 Abbott ARCHITECT i4000-2.4% 5.6% 9.77 1 Architect BioTum 19860 Ca 125 U/mL 1 Variabilidad biológica 18.0% 1 105.7 6.40% 29 102.3 1.80% 30 19860 Abbott ARCHITECT i4000-3.2% 6.8% 8.21 1 Architect 19860 Ca 125 U/mL 1 Variabilidad biológica 18.0% 1 264 5.50% 20 256 1.60% 31 19860 Abbott ARCHITECT i4000-3.1% 6.3% 9.28 1 Architect 19860 Ca 15-3 1 Variabilidad biológica 21.0% 1 30.0 5.20% 22 29.7 4.00% 5 19860 Abbott ARCHITECT i4000-1.2% 9.2% 4.94 1 Architect BioTum 19860 Ca 15-3 U/mL 1 Variabilidad biológica 21.0% 1 69.2 5.50% 21 73.7 3.20% 22 19860 Abbott ARCHITECT i4000 6.6% 13.0% 4.51 1 Architect 19860 Ca 15-3 U/mL 1 Variabilidad biológica 21.0% 1 116.0 6.20% 13 125.5 2.70% 23 19860 Abbott ARCHITECT i4000 8.2% 13.6% 4.74 2 Architect 19860 TG 1 Variabilidad biológica 33.0% 2 4.67 9.60% 9 4.58 9.60% 2 19860 Siemens IMMULITE 2000-1.9% 21.1% 3.24 2 Architect BioTum 19860 TG ng/ml 1 Variabilidad biológica 33.0% 2 57.2 8.30% 8 55.6 8.40% 9 19860 Siemens IMMULITE 2000-2.7% 19.5% 3.61 2 Architect 19860 TG ng/ml 1 Variabilidad biológica 33.0% 2 146.1 8.40% 9 143.0 6.30% 9 19860 Siemens IMMULITE 2000-2.1% 14.7% 4.90 2 Architect C BIORAD 52360 ASTO UI/mL 1 CLIA 13.2% 2 85.7 10.30% 1 91.3 9.00% 14 52410 BioSystems 6.6% 24.6% 0.74 2 Architect C BIORAD 52360 ASTO UI/mL CLIA 13.2% 2 52410 BioSystems 2 Architect C BIORAD 52360 ASTO UI/mL 1 CLIA 13.2% 2 196 5.20% 1 203 2.50% 12 52410 BioSystems 3.7% 8.7% 3.79 2 Architect C BIORAD 52360 APO A mg/dl 1 CFX 10.0% 2 83.4 3.40% 3 83.4 1.30% 13 52410 Abbott ARCHITECT c8000 0.0% 2.6% 7.67 2 Architect C BIORAD 52360 APO A mg/dl CFX 10.0% 2 52410 Abbott ARCHITECT c8000 2 Architect C BIORAD 52360 APO A mg/dl 1 CFX 10.0% 2 258 2.30% 2 258 0.60% 13 52410 Abbott ARCHITECT c8000 0.2% 1.4% 16.28 2 Architect C BIORAD 52360 APO B mg/dl 1 CFX 12.0% 2 40.9 4.00% 3 39.5 2.20% 14 52410 Abbott ARCHITECT c8000-3.5% 7.9% 3.88 2 Architect C BIORAD 52360 APO B mg/dl CFX 12.0% 2 52410 Abbott ARCHITECT c8000 2 Architect C BIORAD 52360 APO B mg/dl 1 CFX 12.0% 2 140.2 1.90% 2 137.8 1.50% 14 52410 Abbott ARCHITECT c8000-1.7% 4.7% 6.86 Fecha de impresión: 08/11/2011 Página 3/4

Desempeño analítico - MENSUAL Sep-11 165 Lab (Mód) Analizador Control Lote Analito Unid Activo ETa Laboratorio Criterio Valor Grupo PAR (Acum) Media Nº Labs CV Media CV Lote Analizador NºRes Sesgo (CCI) Laboratorio 2 Architect C BIORAD 52360 C3 mg/dl 1 Variabilidad biológica 9.0% 2 80.7 3.10% 12 79.7 1.20% 22 52410 Abbott ARCHITECT c8000-1.3% 3.7% 6.41 ET Sigma 2 Architect C BIORAD 52360 C3 mg/dl Variabilidad biológica 9.0% 2 165.6 3.10% 12 52410 Abbott ARCHITECT c8000 2 Architect C BIORAD 52360 C3 mg/dl 1 Variabilidad biológica 9.0% 2 243 2.90% 12 245 1.40% 22 52410 Abbott ARCHITECT c8000 0.5% 3.3% 6.11 2 Architect C BIORAD 52360 C4 mg/dl 1 Variabilidad biológica 16.0% 2 14.14 3.80% 12 13.87 1.40% 24 52410 Abbott ARCHITECT c8000-1.9% 4.7% 10.06 2 Architect C BIORAD 52360 C4 mg/dl Variabilidad biológica 16.0% 2 30.1 3.30% 12 52410 Abbott ARCHITECT c8000 2 Architect C BIORAD 52360 C4 mg/dl 1 Variabilidad biológica 16.0% 2 43.6 3.10% 12 43.1 1.20% 24 52410 Abbott ARCHITECT c8000-1.2% 3.6% 12.34 2 Architect C BIORAD 52360 FR UI/mL 1 Variabilidad biológica 20.0% 2 32.4 6.50% 1 33.2 7.80% 5 52410 BioSystems 2.5% 18.1% 2.24 2 Architect C BIORAD 52360 FR UI/mL Variabilidad biológica 20.0% 2 52410 BioSystems 2 Architect C BIORAD 52360 FR UI/mL 1 Variabilidad biológica 20.0% 2 96.5 5.40% 1 95.8 9.30% 5 52410 BioSystems -0.7% 19.3% 2.08 2 Architect C BIORAD 52360 IgA mg/dl 1 Variabilidad biológica 14.0% 2 120.5 2.60% 9 119.9 1.40% 26 52410 Abbott ARCHITECT c8000-0.5% 3.3% 9.64 2 Architect C BIORAD 52360 IgA mg/dl Variabilidad biológica 14.0% 2 238 2.50% 9 52410 Abbott ARCHITECT c8000 2 Architect C BIORAD 52360 IgA mg/dl 1 Variabilidad biológica 14.0% 2 348 2.00% 9 351 1.10% 26 52410 Abbott ARCHITECT c8000 1.0% 3.2% 11.81 2 Architect C BIORAD 52360 IgG mg/dl 1 Variabilidad biológica 8.0% 2 979 1.80% 8 979 1.10% 24 52410 Abbott ARCHITECT c8000 0.0% 2.2% 7.25 2 Architect C BIORAD 52360 IgG mg/dl Variabilidad biológica 8.0% 2 1911 3.10% 8 52410 Abbott ARCHITECT c8000 2 Architect C BIORAD 52360 IgG mg/dl 1 Variabilidad biológica 8.0% 2 2481 3.70% 8 2481 1.00% 24 52410 Abbott ARCHITECT c8000 0.0% 2.0% 8.00 2 Architect C BIORAD 52360 IgM mg/dl 1 CLIA 15.0% 2 62.4 4.60% 9 62.3 2.30% 24 52410 Abbott ARCHITECT c8000-0.2% 4.8% 6.44 2 Architect C BIORAD 52360 IgM mg/dl CLIA 15.0% 2 133.7 3.70% 9 52410 Abbott ARCHITECT c8000 2 Architect C BIORAD 52360 IgM mg/dl 1 CLIA 15.0% 2 194 2.60% 9 196 1.20% 24 52410 Abbott ARCHITECT c8000 0.8% 3.2% 11.81 2 Architect C BIORAD 52360 PCR mg/l 1 Variabilidad biológica 57.0% 2 4.40 23.50% 1 5.05 16.50% 13 52410 BioSystems 14.8% 47.8% 2.56 2 Architect C BIORAD 52360 PCR mg/l Variabilidad biológica 57.0% 2 52410 BioSystems 2 Architect C BIORAD 52360 PCR mg/l 1 Variabilidad biológica 57.0% 2 47.6 5.30% 1 49.2 3.90% 13 52410 BioSystems 3.3% 11.1% 13.76 2 Architect C BIORAD 52360 PT g/dl 1 CLIA 10.0% 2 6.53 2.10% 74 6.53 1.20% 28 14190 Abbott ARCHITECT c8000 0.0% 2.4% 8.33 2 Architect C BIORAD 52360 PT g/dl 1 CLIA 10.0% 2 4.23 2.60% 75 4.24 1.20% 29 14190 Abbott ARCHITECT c8000 0.2% 2.6% 8.14 2 Architect C BIORAD 52360 PT g/dl CLIA 10.0% 2 14190 Abbott ARCHITECT c8000 2 Architect C BIORAD 52360 TRF mg/dl 1 WLSH 8.8% 2 150.4 2.30% 27 149.3 1.60% 18 52410 Abbott ARCHITECT c8000-0.7% 3.9% 5.04 2 Architect C BIORAD 52360 TRF mg/dl WLSH 8.8% 2 253 2.10% 23 52410 Abbott ARCHITECT c8000 2 Architect C BIORAD 52360 TRF mg/dl 1 WLSH 8.8% 2 346 1.90% 26 344 0.90% 19 52410 Abbott ARCHITECT c8000-0.4% 2.2% 9.33 1 Variant II BIORAD 52360 HBA1C % 1 CLIA 10.0% 1 5.65 3.10% 61 5.71 1.90% 24 33810 BioRad VARIANT II 1.1% 4.9% 4.70 1 Variant II BIORAD 52360 HBA1C % 1 CLIA 10.0% 1 9.64 2.40% 60 9.65 1.70% 22 33810 BioRad VARIANT II 0.1% 3.5% 5.82 1 Variant II BIORAD 52360 HBA1C % CLIA 10.0% 1 33810 BioRad VARIANT II 2 Variant II BIORAD 52360 HBA1C % 1 CLIA 10.0% 2 5.65 3.10% 61 5.73 1.60% 25 33810 BioRad VARIANT II 1.4% 4.6% 5.37 2 Variant II BIORAD 52360 HBA1C % 1 CLIA 10.0% 2 9.64 2.40% 60 9.68 1.80% 22 33810 BioRad VARIANT II 0.4% 4.0% 5.33 2 Variant II BIORAD 52360 HBA1C % CLIA 10.0% 2 33810 BioRad VARIANT II Fecha de impresión: 08/11/2011 Página 4/4

EVOLUCIÓN DEL DESEMPEÑO ANALÍTICO 1 AFP M2 2 1 CEA M1 2 3 19.2 22.0% 97.5 22.0% 2.97 25.0% 21.34 25.0% 48.75 25.0% 1 13.07 25.0% INS M1 2 41.73 25.0% 3 126.1 25.0% 1 0.657 34.0% PSA M1 2 2.52 34.0% 3 15.57 34.0% 1 0.423 20.0% PSAL M1 2 1.59 20.0% 1 69.56 28.2% T3 M1 2 194.5 20.0% 3 274.9 20.0% CV 9 2.90% 4.00% 4.00% 4.50% 5.72% Sesgo 14-1.88% -0.83% 1.93% 0.68% 0.84% Sigma 16 6.94 5.29 5.02 4.74 3.70 CV 9 1.40% 2.30% 3.70% 4.50% 4.33% Sesgo 14 0.37% -0.15% 1.13% -1.42% 1.22% Sigma 16 15.45 9.50 5.64 4.57 4.80 CV 9 4.40% 5.30% 4.40% 3.70% 3.80% Sesgo 14 3.03% 2.68% 4.03% 3.02% 6.73% Sigma 16 4.99 4.21 4.77 5.94 4.81 CV 9 2.90% 3.00% 3.30% 3.30% 3.20% Sesgo 14-1.97% -2.90% -1.17% -1.59% -0.38% Sigma 16 7.94 7.37 7.22 7.09 7.70 CV 9 2.80% 3.20% 2.20% 3.70% 2.20% Sesgo 14-2.71% -4.42% -2.34% -2.50% -1.41% Sigma 16 7.96 6.43 10.30 6.08 10.72 CV 9 2.80% 3.00% 3.90% 1.30% 3.80% Sesgo 14-2.07% -1.53% -2.15% -1.38% -3.69% Sigma 16 8.19 7.82 5.86 18.17 5.61 CV 9 2.50% 3.30% 3.90% 2.80% 2.10% Sesgo 14-2.68% -1.39% -0.79% -1.56% -2.54% Sigma 16 8.93 7.15 6.21 8.37 10.69 CV 9 2.00% 3.00% 2.90% 2.10% 2.10% Sesgo 14-1.27% -0.87% -0.40% -0.72% -1.83% Sigma 16 11.87 8.04 8.48 11.56 11.03 CV 9 4.80% 4.50% 4.10% 3.60% 5.20% Sesgo 14-8.07% -3.19% -3.80% -5.18% -5.04% Sigma 16 5.40 6.85 7.37 8.01 5.57 CV 9 3.90% 4.50% 4.40% 3.20% 5.50% Sesgo 14-7.54% -3.57% -3.57% -6.35% -5.98% Sigma 16 6.78 6.76 6.92 8.64 5.10 CV 9 4.50% 4.20% 4.40% 4.20% 5.20% Sesgo 14-1.03% -0.77% -2.64% -2.64% -2.33% Sigma 16 7.33 7.91 7.13 7.47 6.09 CV 9 3.00% 2.80% 2.20% 2.73% 2.90% Sesgo 14-4.26% -1.18% -2.35% -4.00% -1.41% Sigma 16 5.25 6.72 8.02 5.86 6.41 CV 9 2.90% 3.50% 3.50% 2.35% 2.60% Sesgo 14-3.77% -0.63% -2.52% -4.38% -1.87% Sigma 16 5.60 5.53 5.00 6.65 6.97 CV 9 6.60% 5.20% 6.70% 5.90% 5.60% Sesgo 14-3.59% -3.91% -3.58% -1.81% -1.17% Sigma 16 3.73 4.67 3.67 4.47 4.82 CV 9 4.90% 2.80% 2.50% 2.70% 2.40% Sesgo 14-4.83% -0.61% -2.92% -1.43% 0.26% Sigma 16 3.10 6.92 6.83 6.88 8.23 CV 9 4.60% 3.10% 2.50% 2.80% 2.20% Sesgo 14-0.33% 0.72% -1.73% -0.25% 0.65% Sigma 16 4.28 6.22 7.31 7.05 8.80 Fechad e impresión: 08/11/2011 Página 1/8

EVOLUCIÓN DEL DESEMPEÑO ANALÍTICO 1 2.07 30.0% T3L M1 2 6.14 30.0% 3 11.18 30.0% 1 5.05 20.0% T4 M1 2 11.4 20.0% 3 18.47 20.0% 1 0.898 15.0% T4L M1 2 2.28 15.0% 1 0.407 24.0% TSH M1 2 4.42 24.0% 3 27.24 24.0% 1 6 32.0% BHCG M2 2 31.29 32.0% 3 268.5 32.0% 1 2.46 25.0% CMZ M2 2 12.88 25.0% CV 9 7.50% 8.80% 8.10% 7.70% 4.60% Sesgo 14-5.80% -6.76% -3.38% -8.25% -5.83% Sigma 16 3.23 2.64 3.29 2.82 5.26 CV 9 3.40% 2.50% 1.70% 3.50% 3.30% Sesgo 14-3.26% -6.01% -3.41% -5.67% -2.27% Sigma 16 7.87 9.60 15.64 6.95 8.40 CV 9 4.00% 4.70% 4.50% 4.20% 4.40% Sesgo 14-1.25% -9.56% -2.23% -3.22% -1.35% Sigma 16 7.19 4.35 6.17 6.38 6.51 CV 9 0.00% 3.10% 3.60% 2.60% 4.60% Sesgo 14-0.79% -1.58% 0.00% 0.80% Sigma 16 6.20 5.12 7.69 4.17 CV 9 0.00% 4.20% 2.10% 2.50% 3.30% Sesgo 14 0.09% -4.03% -4.37% -2.19% Sigma 16 4.74 7.61 6.25 5.40 CV 9 0.00% 4.30% 3.10% 3.00% 5.60% Sesgo 14 0.00% -5.22% -5.89% -2.35% Sigma 16 4.65 4.77 4.70 3.15 CV 9 2.80% 3.10% 2.90% 2.90% 2.80% Sesgo 14-0.89% 0.00% 1.56% 0.33% -2.11% Sigma 16 5.04 4.84 4.63 5.06 4.60 CV 9 3.60% 3.30% 3.60% 2.70% 3.40% Sesgo 14-2.19% 0.88% 2.19% 0.87% 0.00% Sigma 16 3.56 4.28 3.56 5.23 4.41 CV 9 2.50% 3.60% 3.60% 2.80% 5.00% Sesgo 14-5.41% -3.43% -2.44% -6.34% -5.12% Sigma 16 7.44 5.71 5.99 6.31 3.78 CV 9 2.90% 2.60% 3.90% 1.80% 2.70% Sesgo 14-2.94% -1.13% -2.03% -4.94% -3.82% Sigma 16 7.26 8.80 5.63 10.59 7.47 CV 9 2.50% 3.80% 3.90% 2.90% 2.40% Sesgo 14 7.20% 7.71% 3.63% 1.10% 1.25% Sigma 16 6.72 4.29 5.22 7.90 9.48 CV 9 7.60% 8.00% 6.00% 7.10% 8.10% Sesgo 14-3.17% -6.78% -19.83% -11.79% -12.26% Sigma 16 3.79 3.15 2.03 2.85 2.44 CV 9 6.80% 6.70% 6.00% 5.70% 7.10% Sesgo 14-10.10% -11.28% -16.21% -12.90% -10.75% Sigma 16 3.22 3.09 2.63 3.35 2.99 CV 9 5.60% 4.00% 4.00% 5.00% 5.30% Sesgo 14-4.39% -7.31% -6.85% -1.90% -2.82% Sigma 16 4.93 6.17 6.29 6.02 5.51 CV 9 4.25% 3.20% 4.48% 3.90% 4.70% Sesgo 14 10.16% -0.36% 13.06% 0.71% 5.36% Sigma 16 3.49 7.70 2.66 6.23 4.18 CV 9 4.40% 2.40% 4.24% 4.70% 5.10% Sesgo 14 12.11% -2.16% 10.85% 0.42% 0.77% Sigma 16 2.93 9.52 3.34 5.23 4.75 Fechad e impresión: 08/11/2011 Página 2/8

EVOLUCIÓN DEL DESEMPEÑO ANALÍTICO 1 2.62 30.0% CORT M2 2 15.57 30.0% 3 26.43 30.0% 1 1.22 46.0% D4 M2 2 5.51 46.0% 1 6.55 25.0% DFH M2 2 23.11 25.0% 1 60.32 30.0% DHEAS M1 2 123.8 30.0% 3 503.2 30.0% 1 63.84 46.4% E2 M2 2 186.2 25.0% 3 296.8 25.0% 1 9.29 20.0% FENO M2 2 53.19 20.0% 1 65.88 25.0% FER M2 2 150.8 25.0% 3 379.8 25.0% CV 9 6.50% 7.10% 7.20% 4.20% 5.80% Sesgo 14 1.91% 1.15% 6.15% 6.90% 4.63% Sigma 16 4.32 4.06 3.31 5.50 4.37 CV 9 4.30% 3.70% 4.40% 3.60% 4.30% Sesgo 14-0.13% -0.26% -0.78% -0.91% -0.65% Sigma 16 6.95 8.04 6.64 8.08 6.83 CV 9 4.60% 3.90% 3.50% 3.10% 3.80% Sesgo 14-2.08% -1.33% -2.10% -1.53% -1.77% Sigma 16 6.07 7.35 7.97 9.18 7.43 CV 9 11.80% 12.50% 8.70% 11.00% 9.20% Sesgo 14-12.30% -2.48% -5.79% -2.48% -3.28% Sigma 16 2.86 3.48 4.62 3.96 4.64 CV 9 8.40% 7.80% 6.50% 7.10% 7.30% Sesgo 14-1.27% -3.26% -4.73% -4.37% -4.36% Sigma 16 5.32 5.48 6.35 5.86 5.70 CV 9 5.90% 6.20% 6.40% 7.30% 7.00% Sesgo 14 0.61% 4.27% 2.26% -3.47% -1.52% Sigma 16 4.13 3.34 3.55 2.95 3.35 CV 9 3.90% 5.30% 4.80% 5.70% 5.40% Sesgo 14 3.63% 0.69% -1.43% 0.35% 0.82% Sigma 16 5.48 4.59 4.91 4.33 4.48 CV 9 6.30% 1.40% 3.90% 7.30% 4.00% Sesgo 14-2.75% -2.62% 6.81% 6.30% -2.42% Sigma 16 4.33 19.56 5.95 3.25 6.90 CV 9 5.60% 2.20% 5.50% 6.90% 3.50% Sesgo 14-3.72% 0.68% 2.60% 1.71% -0.44% Sigma 16 4.69 13.33 4.98 4.10 8.45 CV 9 4.90% 1.60% 3.00% 1.80% 3.50% Sesgo 14-5.43% -0.40% 5.28% 7.75% 1.36% Sigma 16 5.02 18.50 8.24 12.36 8.18 CV 9 9.80% 9.70% 9.60% 9.50% 12.30% Sesgo 14 3.85% 5.65% 4.40% 3.92% -4.21% Sigma 16 4.34 4.20 4.38 4.47 3.43 CV 9 2.70% 2.30% 3.45% 2.70% 2.70% Sesgo 14-1.45% -0.97% -1.55% -1.62% -3.67% Sigma 16 8.72 10.45 6.80 8.66 7.90 CV 9 1.80% 2.00% 3.10% 2.30% 2.40% Sesgo 14-1.75% -1.04% -1.82% -1.48% -2.94% Sigma 16 12.92 11.98 7.48 10.22 9.19 CV 9 4.00% 3.50% 2.89% 4.60% 4.70% Sesgo 14 2.26% 1.72% 2.36% -0.97% -0.94% Sigma 16 4.43 5.22 6.10 4.14 4.06 CV 9 3.20% 2.60% 2.80% 3.10% 4.90% Sesgo 14 2.84% 1.37% 1.80% 0.64% 1.86% Sigma 16 5.36 7.17 6.50 6.25 3.70 CV 9 3.50% 2.30% 2.70% 3.90% 3.67% Sesgo 14 1.78% -0.02% 0.90% 0.48% 4.24% Sigma 16 6.64 10.86 8.92 6.29 5.66 CV 9 10.10% 5.80% 5.20% 2.70% 4.85% Sesgo 14 2.25% 8.25% 8.97% 5.01% 10.18% Sigma 16 2.25 2.89 3.08 7.40 3.05 CV 9 8.70% 6.90% 4.20% 8.10% 5.41% Sesgo 14-1.26% 2.05% 5.27% 3.66% 4.59% Sigma 16 2.73 3.33 4.70 2.63 3.77 Fechad e impresión: 08/11/2011 Página 3/8

EVOLUCIÓN DEL DESEMPEÑO ANALÍTICO 1 2.65 33.5% FOL M2 2 12.19 30.0% 1 8.06 19.0% FSH M2 2 22.53 19.0% 3 37.65 19.0% 1 182.8 30.0% IGE M2 2 92.04 30.0% 1 1.51 20.0% LH M2 2 16.41 20.0% 3 49.05 20.0% 1 0.661 42.9% PG M2 2 7.69 30.0% 3 28.76 30.0% 1 0.959 31.2% PPC M2 2 4.55 31.2% 1 6.91 21.0% PRL M2 2 22.12 21.0% 3 48.75 21.0% CV 9 6.50% 5.30% 5.80% 6.50% 5.60% Sesgo 14-2.64% -3.73% 3.36% 8.21% 5.58% Sigma 16 4.74 5.61 5.19 3.88 4.98 CV 9 4.90% 4.90% 3.10% 5.40% 7.40% Sesgo 14 1.89% 2.12% 7.06% 8.08% 3.55% Sigma 16 5.74 5.69 7.40 4.06 3.57 CV 9 2.70% 2.80% 3.10% 3.00% 3.80% Sesgo 14-3.60% -3.73% -1.99% -2.61% -5.37% Sigma 16 5.70 5.45 5.49 5.46 3.59 CV 9 2.90% 3.40% 2.70% 2.80% 2.20% Sesgo 14-4.44% -4.93% -2.14% -2.63% -5.15% Sigma 16 5.02 4.14 6.25 5.85 6.30 CV 9 2.80% 3.30% 2.70% 3.00% 2.20% Sesgo 14-3.51% -4.58% -1.49% -1.79% -4.20% Sigma 16 5.53 4.37 6.48 5.74 6.73 CV 9 9.10% 4.20% 5.40% 7.70% 5.91% Sesgo 14-0.93% -2.41% 2.91% 0.82% -2.64% Sigma 16 3.19 6.57 5.02 3.79 4.63 CV 9 7.60% 6.70% 4.60% 6.60% 5.50% Sesgo 14 0.56% 0.98% 3.43% 3.23% 0.22% Sigma 16 3.87 4.33 5.78 4.06 5.42 CV 9 3.50% 5.00% 2.90% 3.50% 3.40% Sesgo 14 1.32% -4.70% 0.68% 3.42% 0.00% Sigma 16 5.34 3.06 6.66 4.74 5.88 CV 9 4.10% 4.00% 3.80% 3.30% 3.30% Sesgo 14-1.28% 0.48% 2.17% 3.06% -1.86% Sigma 16 4.57 4.88 4.69 5.13 5.50 CV 9 4.60% 4.50% 5.90% 4.30% 2.40% Sesgo 14-1.24% 0.00% 2.76% 3.21% -1.75% Sigma 16 4.08 4.44 2.92 3.90 7.61 CV 9 6.20% 6.60% 9.80% 7.80% 8.80% Sesgo 14-1.06% -2.74% -8.09% -0.92% -9.95% Sigma 16 6.75 6.09 3.55 5.38 3.74 CV 9 4.50% 4.00% 6.70% 3.40% 3.70% Sesgo 14 0.52% 3.52% -1.57% 0.92% -3.29% Sigma 16 6.55 6.62 4.24 8.55 7.22 CV 9 6.30% 4.90% 6.80% 4.60% 5.50% Sesgo 14-1.81% 0.45% -4.23% -3.54% -3.41% Sigma 16 4.47 6.03 3.79 5.75 4.83 CV 9 4.80% 2.20% 5.40% 6.20% 1.90% Sesgo 14-1.04% 2.91% -2.38% 6.30% 3.09% Sigma 16 6.28 12.86 5.34 4.02 14.79 CV 9 4.40% 6.90% 2.60% 3.70% 3.50% Sesgo 14-5.05% -8.13% -7.02% -1.97% 0.22% Sigma 16 5.94 3.34 9.30 7.90 8.85 CV 9 3.30% 2.70% 3.10% 3.00% 3.60% Sesgo 14 0.58% 1.16% 0.87% 3.64% 1.75% Sigma 16 6.19 7.35 6.49 5.79 5.35 CV 9 3.10% 2.70% 2.90% 3.00% 3.10% Sesgo 14-4.39% -3.52% -3.29% -3.15% 0.58% Sigma 16 5.36 6.47 6.11 5.95 6.59 CV 9 3.40% 3.20% 3.70% 3.70% 3.90% Sesgo 14-4.00% -4.72% -4.18% -4.26% 1.00% Sigma 16 5.00 5.09 4.54 4.52 5.13 Fechad e impresión: 08/11/2011 Página 4/8

EVOLUCIÓN DEL DESEMPEÑO ANALÍTICO 1 21.88 30.0% PTH M2 2 112.3 30.0% 3 394.9 30.0% 1 5.05 20.0% T4 M2 2 11.4 20.0% 3 18.47 20.0% 1 1.44 30.0% TO M2 2 5.24 30.0% 3 9.41 30.0% 1 0.407 24.0% TSH M2 2 4.42 24.0% 3 27.24 24.0% 1 32.84 25.0% VALP M2 2 128 25.0% 1 434.4 30.0% VB12 M2 2 592.4 30.0% 3 1282 30.0% CV 9 5.40% 6.00% 4.70% 0.00% 7.70% Sesgo 14 0.96% 2.77% 4.05% 1.56% Sigma 16 5.38 4.54 5.52 3.69 CV 9 4.50% 6.00% 6.90% 4.10% 6.70% Sesgo 14-3.21% -2.51% 0.81% -6.15% -2.82% Sigma 16 5.95 4.58 4.23 5.82 4.06 CV 9 2.90% 5.30% 2.40% 3.60% 6.80% Sesgo 14-1.80% -1.91% -0.05% -7.45% -3.52% Sigma 16 9.72 5.30 12.48 6.27 3.89 CV 9 2.70% 3.20% 3.10% 3.40% 4.00% Sesgo 14-2.57% 0.00% 1.58% -1.99% 2.20% Sigma 16 6.45 6.25 5.94 5.30 4.45 CV 9 3.30% 3.70% 3.40% 3.80% 6.80% Sesgo 14-6.14% -1.49% -3.24% -1.84% -6.21% Sigma 16 4.20 5.00 4.93 4.78 2.03 CV 9 4.70% 5.70% 4.50% 4.50% 7.30% Sesgo 14-3.74% -2.06% -5.01% -0.87% -4.16% Sigma 16 3.46 3.15 3.33 4.25 2.17 CV 9 4.90% 5.10% 8.63% 5.54% 5.90% Sesgo 14-4.17% 0.00% 2.78% 1.39% -4.17% Sigma 16 5.27 5.88 3.15 5.16 4.38 CV 9 3.20% 2.60% 4.80% 4.60% 1.30% Sesgo 14-1.34% 2.48% 3.60% 6.79% 8.44% Sigma 16 8.96 10.59 5.50 5.05 16.58 CV 9 3.10% 2.90% 5.20% 4.50% 2.90% Sesgo 14-2.02% 1.06% 0.85% 3.79% 6.81% Sigma 16 9.03 9.98 5.61 5.82 8.00 CV 9 2.80% 2.80% 2.70% 2.70% 2.40% Sesgo 14-3.44% -1.96% 0.24% -2.93% -2.68% Sigma 16 7.34 7.87 8.80 7.80 8.88 CV 9 3.20% 3.70% 3.40% 2.90% 2.80% Sesgo 14-2.26% -0.68% 0.23% -3.15% -2.70% Sigma 16 6.79 6.30 6.99 7.19 7.61 CV 9 4.30% 4.10% 4.20% 3.30% 3.20% Sesgo 14 4.26% 4.04% 3.78% 1.72% 1.50% Sigma 16 4.59 4.87 4.82 6.75 7.03 CV 9 3.60% 3.40% 3.70% 4.70% 3.50% Sesgo 14 1.22% -1.71% -1.93% -0.83% -2.12% Sigma 16 6.61 6.85 6.24 5.14 6.54 CV 9 2.40% 3.90% 2.90% 3.90% 3.20% Sesgo 14-2.42% -3.14% -2.59% -1.58% -1.42% Sigma 16 9.41 5.61 7.73 6.01 7.37 CV 9 8.50% 4.10% 5.90% 9.50% 6.40% Sesgo 14-1.47% 3.68% 2.86% -2.63% -1.87% Sigma 16 3.36 6.42 4.60 2.88 4.40 CV 9 5.96% 4.00% 6.40% 6.40% 4.80% Sesgo 14 1.11% 2.97% 4.42% 0.56% -0.69% Sigma 16 4.85 6.76 4.00 4.60 6.11 CV 9 4.14% 6.30% 6.40% 7.80% 5.50% Sesgo 14-2.18% 5.78% 2.81% 4.29% 1.63% Sigma 16 6.72 3.84 4.25 3.30 5.16 Fechad e impresión: 08/11/2011 Página 5/8

EVOLUCIÓN DEL DESEMPEÑO ANALÍTICO 1 1498 30.0% B2MG M2 2 3086 30.0% 3 5786 30.0% 1 53.56 18.0% Ca 125 M1 2 106.5 18.0% 3 265.6 18.0% 1 14.42 39.0% Ca 19-9 M2 2 88.44 39.0% 3 281.1 39.0% 1 30.14 21.0% Ca 15-3 M1 2 69.19 21.0% 3 115.4 21.0% 1 4.74 33.0% TG M2 2 57.81 33.0% 3 148.3 33.0% CV 9 4.70% 3.90% 4.80% 6.10% 2.10% Sesgo 14-1.27% -1.34% 4.67% 5.67% 7.99% Sigma 16 6.11 7.35 5.28 3.99 10.48 CV 9 7.30% 5.20% 6.30% 4.50% 2.30% Sesgo 14-0.58% -1.56% 2.18% 4.51% 2.43% Sigma 16 4.03 5.47 4.42 5.66 11.99 CV 9 5.70% 5.90% 5.80% 6.10% 4.20% Sesgo 14 4.65% -3.06% -1.35% 3.12% 2.13% Sigma 16 4.45 4.57 4.94 4.41 6.64 CV 9 2.41% 1.45% 2.00% 1.10% 1.60% Sesgo 14-2.56% -2.08% 3.18% 1.09% -2.36% Sigma 16 6.41 10.98 7.41 15.38 9.77 CV 9 2.40% 2.08% 2.10% 1.90% 1.80% Sesgo 14-2.86% -2.41% -3.58% -1.61% -3.22% Sigma 16 6.31 7.50 6.87 8.63 8.21 CV 9 2.82% 1.92% 2.00% 0.70% 1.60% Sesgo 14-3.37% -2.97% -4.57% -0.08% -3.15% Sigma 16 5.19 7.83 6.72 25.61 9.28 CV 9 8.70% 7.30% 8.10% 9.60% 3.50% Sesgo 14-5.20% -3.48% -10.82% -7.33% -2.31% Sigma 16 3.88 4.87 3.48 3.30 10.48 CV 9 8.60% 7.60% 9.30% 8.60% 7.90% Sesgo 14-1.97% -4.06% -7.26% -7.35% -0.74% Sigma 16 4.31 4.60 3.41 3.68 4.84 CV 9 5.80% 6.10% 7.30% 6.40% 5.60% Sesgo 14 0.21% -0.78% 1.42% 4.32% 5.85% Sigma 16 6.69 6.27 5.15 5.42 5.92 CV 9 3.40% 3.90% 2.80% 1.60% 4.00% Sesgo 14-0.13% -2.26% -3.39% 1.13% -1.23% Sigma 16 6.14 4.81 6.29 12.42 4.94 CV 9 3.80% 4.60% 3.20% 6.20% 3.20% Sesgo 14 0.92% -0.51% -1.36% 0.00% 6.56% Sigma 16 5.28 4.46 6.14 3.39 4.51 CV 9 3.70% 4.70% 3.50% 6.70% 2.70% Sesgo 14 3.29% 1.73% 0.09% 1.47% 8.19% Sigma 16 4.79 4.10 5.98 2.91 4.74 CV 9 8.70% 3.60% 8.10% 5.50% 9.60% Sesgo 14-13.29% -13.11% -10.45% -13.25% -1.93% Sigma 16 2.27 5.53 2.78 3.59 3.24 CV 9 5.40% 5.80% 4.10% 4.20% 8.40% Sesgo 14-3.30% -4.76% -0.68% -2.09% -2.66% Sigma 16 5.50 4.87 7.88 7.36 3.61 CV 9 4.30% 4.50% 6.30% 8.10% 6.30% Sesgo 14-4.25% -5.01% -0.34% -5.46% -2.12% Sigma 16 6.69 6.22 5.18 3.40 4.90 Fechad e impresión: 08/11/2011 Página 6/8

EVOLUCIÓN DEL DESEMPEÑO ANALÍTICO 1 84.34 10.0% APO A M2 2 248.7 10.0% 1 40.67 12.0% APO B M2 2 139.7 12.0% 1 82 9.0% C3 M2 2 242.3 9.0% 1 14.11 16.0% C4 M2 2 44.94 16.0% 1 117.2 14.0% IgA M2 2 335.6 14.0% 1 928.2 8.0% IgG M2 2 2515 8.0% 1 61.55 15.0% IgM M2 2 206 15.0% 1 3.19 10.0% PT M2 2 0 10.0% 1 150.7 8.8% TRF M2 2 332.9 8.8% CV 9 1.30% 1.60% 0.70% 1.50% 1.30% Sesgo 14-1.51% -0.83% -3.34% -0.02% 0.02% Sigma 16 6.53 5.73 9.51 6.65 7.67 CV 9 1.10% 1.20% 0.40% 0.70% 0.60% Sesgo 14 1.53% 2.17% 1.02% 0.86% 0.23% Sigma 16 7.70 6.52 22.44 13.06 16.28 CV 9 1.70% 1.30% 1.40% 2.20% 2.20% Sesgo 14-5.41% -2.59% -6.81% -4.80% -3.47% Sigma 16 3.88 7.24 3.71 3.27 3.88 CV 9 2.10% 1.20% 0.90% 1.30% 1.50% Sesgo 14-3.94% -2.01% -1.84% -1.49% -1.71% Sigma 16 3.84 8.32 11.29 8.08 6.86 CV 9 1.30% 1.30% 0.80% 1.30% 1.20% Sesgo 14 0.72% 1.47% -0.07% 0.04% -1.31% Sigma 16 6.37 5.79 11.16 6.89 6.41 CV 9 0.80% 1.20% 1.00% 1.50% 1.40% Sesgo 14 0.12% 1.77% 1.27% 0.82% 0.45% Sigma 16 11.10 6.02 7.73 5.45 6.11 CV 9 1.10% 1.10% 1.40% 0.70% 1.40% Sesgo 14-2.06% -2.06% -1.43% -1.70% -1.91% Sigma 16 12.68 12.67 10.41 20.42 10.06 CV 9 1.30% 1.10% 0.70% 0.80% 1.20% Sesgo 14-1.65% -1.05% -0.74% -0.83% -1.19% Sigma 16 11.04 13.59 21.81 18.97 12.34 CV 9 1.90% 1.00% 1.70% 1.20% 1.40% Sesgo 14 0.77% 1.62% -0.50% 0.33% -0.50% Sigma 16 6.96 12.38 7.94 11.39 9.64 CV 9 1.26% 1.20% 1.00% 1.40% 1.10% Sesgo 14 0.79% 0.51% -0.43% 1.50% 1.01% Sigma 16 10.48 11.25 13.57 8.93 11.81 CV 9 1.40% 1.30% 0.80% 1.00% 1.10% Sesgo 14 0.32% -0.45% -0.23% 0.14% 0.02% Sigma 16 5.48 5.81 9.71 7.86 7.25 CV 9 1.30% 0.90% 1.00% 2.00% 1.00% Sesgo 14-0.44% -0.08% 0.45% 0.77% 0.00% Sigma 16 5.82 8.80 7.55 3.62 8.00 CV 9 3.20% 3.10% 2.80% 3.50% 2.30% Sesgo 14 1.51% 0.85% 0.76% -1.27% -0.19% Sigma 16 4.22 4.56 5.09 3.92 6.44 CV 9 2.20% 1.60% 1.00% 1.50% 1.20% Sesgo 14 1.17% 1.21% -0.66% -0.51% 0.83% Sigma 16 6.29 8.62 14.34 9.66 11.81 CV 9 2.30% 1.00% 1.20% 1.20% 1.20% Sesgo 14 0.00% -0.15% 2.15% 0.92% 0.00% Sigma 16 4.35 9.85 6.54 7.57 8.33 CV 9 0.00% 0.90% 1.10% 1.10% 1.20% Sesgo 14-0.24% 1.42% 1.18% 0.24% Sigma 16 10.85 7.80 8.02 8.14 CV 9 0.60% 1.20% 1.50% 1.10% 1.60% Sesgo 14-1.39% -1.06% -0.47% -0.80% -0.73% Sigma 16 12.34 6.45 5.56 7.27 5.04 CV 9 0.80% 0.90% 0.50% 1.00% 0.90% Sesgo 14 0.27% 0.00% -0.64% 0.03% -0.41% Sigma 16 10.66 9.78 16.33 8.77 9.33 Fechad e impresión: 08/11/2011 Página 7/8

Analito HBA1C M1 HBA1C M2 Nivel ETa 1 5.63 10.0% 2 9.67 10.0% 1 5.63 10.0% 2 9.67 10.0% EVOLUCIÓN DEL DESEMPEÑO ANALÍTICO CV 9 1.40% 1.20% 2.00% 1.90% 1.90% Sesgo 14 0.00% -0.35% -0.35% 0.71% 1.06% Sigma 16 7.14 8.04 4.82 4.89 4.70 CV 9 1.30% 1.50% 1.70% 1.40% 1.70% Sesgo 14-0.41% -1.14% -0.41% -0.21% 0.10% Sigma 16 7.37 5.91 5.64 6.99 5.82 CV 9 1.80% 1.90% 1.50% 1.60% 1.60% Sesgo 14 1.07% 0.00% -0.18% 1.42% 1.42% Sigma 16 4.96 5.26 6.55 5.37 5.37 CV 9 1.20% 1.30% 1.70% 1.30% 1.80% Sesgo 14-0.41% -0.93% 1.14% -0.10% 0.41% Sigma 16 7.99 6.98 5.21 7.61 5.33 Fechad e impresión: 08/11/2011 Página 8/8

Evaluación de Desempeño - Observaciones Período Analito Observación Desempeño (Control de calidad Interno) Control externo RIQAS T3L Ha presentado históricamente un desempeño pobre en el nivel bajo, se está intentando bajar el CV% con un seguimiento más estricto del CCI. Resultados aceptados (8/8 muestras) en todos los niveles. T4 βhcg DFH En el mes de setiembre ha presentado un cambio de comportamiento, existen dos poblaciones de datos durante el mes que producen una sobreestimación del CV%, el cual volverá a valores habituales en el mes de octubre. Se observa un sesgo negativo en niveles medios y bajos, que fue elevado a Siemens para su inveswtigación. Se atribuye a un desplazamiento gradual de la media del grupo par. Tanto la media de BAIRES como la del grupo par han disminuido, se espera que se ajusten en los próximos meses. Si bien su desempeño ha mejorado, muestra históricamente un alto CV% en valores bajos. Se está estudiando cambiar el método a Architect i4000 o c8000, como ya se hizo con otras drogas con buenos resultados. Resultados aceptados (8/8 muestras) Se observa un sesgo negativo (aprox. 10% de promedio) en un rango de valores más amplio. Se volverá a consultar a Siemens con estos nuevos datos que refuerzan las observaciones del CCI. Tuvimos 1 rechazo en 8 muestras. Resultados aceptados (8/8 muestras) CARB Se ha cambiado de método (a Abbott Architect c8000). Los valores de mayo y julio corresponden a Immulite 2000, con el que manteníamos un sesgo positivo con respecto al grupo par. La comparación entre ambos métodos ha sido satisfactoria. El grupo par en Abbott es reducido. Resultados aceptados (7/7 muestras) por turbidimetría Abbott. El grupo par en RIQAS tiene mayor número de laboratorios (N=11) FER Se han mantenido las irregularidades en el comportamiento de los Biorad 2 y 3. Hemos elevado el problema a Biodiagnóstico, de donde aún no hemos tenido una respuesta concreta. Resultados aceptados (8/8 muestras) TG Se mantuvo el sesgo negativo en el BIORAD 1. Se elevó el problema a Siemens y la respuesta fue que intentemos cambiar la forma de manipulación del control en el momento de fraccionarlo, lo cual se está estudiando ahora. Resultados aceptados (8/8 muestras) en todos los niveles. Impreso en la fecha: 08/11/2011 Página 1/1